Depression and inflammation linked to pain in rheumatoid arthritis patients

	Tweet

Rheumatoid Arthritis (RA) is a chronic autoimmune disease that causes inflammation of the joints and surrounding tissues. More than 1.3 million adults in the U.S. suffer from RA with 75% of those afflicted being women. Patients with RA experience pain, stiffness, swelling, and deterioration of joints. Severe chronic pain accompanied by progressive joint destruction, disability, and disfigurement is known to increase the risk of experiencing emotional disturbances, with RA patients twice as likely to be depressed as people in the general population. Emotional wellness for persons with RA plays a critical role in disease course and disability.

Researchers at Nagoya City University and Nagoya University Graduate Schools of Medicine in Japan studied the interrelationship between levels of depression symptoms, C-reactive protein (CRP) level, and pain, confirming a significant positive association between depressive symptoms and CRP level in RA. A second study by researchers at the University of British Columbia in Canada further explored depression in spouses of persons with RA, finding that higher levels of spouse depression predicted worse disease course for the person with RA over a 1-year period. Both studies are published in the August issue of Arthritis Care & Research, a journal of the American College of Rheumatology.

The Nagoya research team, led by Masayo Kojima, M.D., Ph.D., evaluated 218 RA patients who completed self-administered questionnaires that surveyed their sociodemographic characteristics, smoking and drinking habits, onset year of RA, and current pain, and a well-validated self-report inventory used to assess the severity of depressive symptoms.

Blood samples from study participants were taken to measure their CRP levels. CRP is a plasma protein that is produced by the liver and rises during incidents of acute inflammation such as found in RA. RA treatments are often focused on reducing such inflammation.

According to this study, the inflammation and depression each independently increased the likelihood of severe pain. The combined effects of high CRP levels and depression predicted severe pain even more strongly.

“Results of our research demonstrate the potential for clinicians to improve pain control by addressing their patients’ psychological symptoms in addition to conducting anti-inflammation therapy,” stated Dr. Kojima. The study indicates for those patients reporting severe pain without CRP level elevation, psychotherapy and/or psychotropic medication might have priority. “A clinical approach that takes into account both the body and the mind could have benefits and could enable optimal pain control,” recommend the authors.

Anita DeLongis, Ph.D. and colleagues from the University of British Columbia examined the role of spouse mood in the disability and disease course of RA patients. A total of 133 married RA patients completed questionnaires, including the Rheumatoid Arthritis Disease Activity Index and the Disabilities of the Arm, Shoulder, and Hand, assessing RA disease activity and disability at two time points one year apart. Both the patients and their spouses completed the Center for Epidemiologic Studies Depression Scale, a standardized community measure of depression at both time points.

Higher levels of spouse depressive symptoms at the initial assessment predicted worse disease course over a one-year period for their partners with RA, even after controlling for characteristics of the person with RA such as initial levels of depression, disability, disease activity, age, number of years married, education, disease duration, and employment.

“Our findings highlight the key role played by the spouse in disease course of individuals with RA, and point to the importance of including the spouse in clinical interventions,” concluded the authors. “The mood and mental health of the marital partner or other key members of the family may be critically important to consider in developing more effective and evidence-based treatment for RA patients,” added Dr. DeLongis.

###

Article: “Depression, Inflammation, and Pain in Patients with Rheumatoid Arthritis,” Masayo Kojima, Toshihisa Kojima, Sadao Suzuki, Takeshi Oguchi, Michinari Oba, Hiroki Tsuchiya, Fumiaki Sugiura, Yasuhide Kanayama, Toshiaki A. Furukawa, Shinkan Tokudome, Naoki Ishiguro, Arthritis Care & Research, August 2009. http://www3.interscience.wiley.com/journal/122526339/abstract

Article: “Spouse Depression and Disease Course Among Persons With Rheumatoid Arthritis,” Mark Lam, Allen J. Lehman, Eli Puterman, Anita DeLongis, Arthritis Care & Research, August 2009.

Contact: Dawn Peters

781-388-8930
Wiley-Blackwell

RELATED STORIES:
Alzheimer’s risk: Would you want to know?   Clinical Trial of Fluoxetine in Anxiety and Depression in Children, and Associated Brain Changes   Depression tied to low folate levels   Check list for dementia and its all about lifestyle   Happy People Are Healthier, Carnegie Mellon Psychologist Says   Brain waves show sound processing abnormalities in autistic children   Brain Tumor Surgery: Study Investigates Connection between Depression and Survival   ADHD linked to mom’s iodine levels   Depression frequent and highly persistent in 85-plus   Depression ups Stroke Risk   New TMS clinic offers noninvasive treatment for major depression   Burn Patients Need More Help Coping With Depression   Heroin by prescription seen to help addicts quit   Working Overtime Linked to Anxiety and Depression   New psychotherapy has potential to treat majority of cases of eating disorders

Comments

[ + Post Your Own ]

Now you're in the public comment zone. What follows is not Armenian Medical Network's stuff; it comes from other people and we don't vouch for it. A reminder: By using this Web site you agree to accept our Terms of Service. Click here to read the Rules of Engagement.

There are no comments for this entry yet. [ + Comment here + ]